个人简历

教育经历\r
1981-1985 沈阳药科大学，工学学士\r
1985-1988 沈阳药科大学，理学硕士\r
1988-2001 沈阳药科大学，理学博士\r
\r
工作经历\r
1988-1990 沈阳药学院药学系药物化学教研室，助教\r
1991-1993 沈阳药学院药物研究所，助理研究员\r
1993-1998 沈阳药学院药物研究所，副研究员\r
1995-1997 美国加州大学旧金山分校药学院，访问学者\r
1998-2001 沈阳药科大学制药工程学院，教授\r
2002-2004 沈阳药科大学制药工程学院，校长助理兼院长\r
2005-2010 沈阳药科大学，校长助理兼国际交流处处长\r
2010-2020 沈阳药科大学，副校长\r
2020至今 沈阳药科大学，校长

研究领域

"""""药物化学/制药工程/分子模拟及计算机辅助药物设计；基于β2受体、质子泵、碳酸酐酶IV、PAKs等药物作用靶点结构的新药发现"

近期论文

Zuo-Peng Zhang, Ye Zhong, Zhen-Bin Han, Lin Zhou, Hua-Sheng Su, Jian Wang, Yang Liu*, Mao-Sheng Cheng*. Synthesis, molecular docking analysis and biological evaluations of saccharide-modified thiadiazole sulfonamide derivatives. International Journal of Molecular Sciences, 2021, 22(11): 5482.\r
\r
Gang Xing, Zhengxing Zhi, Ce Yi, Jitian Zou, Xuefeng Jing, Anthony Yiu-Ho Woo, Bin Lin, Li Pan*, Yuyang Zhang*, Maosheng Cheng*. 8-Hydroxyquinolin-2(1H)-one analogues as potential β2-agonists: Design, synthesis and activity study. European Journal of Medicinal Chemistry, 2021, 224:113697.\r
\r
Gang Xing, Anthony Yiu-Ho Woo*, Li Pan, Bin Lin, Maosheng Cheng*. Recent Advances in β2-Agonists for Treatment of Chronic Respiratory Diseases and Heart Failure. Journal of Medicinal Chemistry, 2020, 63(24): 15218-15242.\r
\r
Gaofei Wei*, Jiahong Sun, Weijing Luan, Zhuang Hou, Shuai Wang, Shanshan Cui, Maosheng Cheng*, Yang Liu*. Natural product Albiziabioside A conjugated with pyruvate dehydrogenase kinase inhibitor dichloroacetate to induce apoptosis-ferroptosis-M2-TAMs polarization for combined cancer therapy. Journal of Medicinal Chemistry, 2019, 62(19): 8760–8772.\r
\r
Qiaolin Tong, Yang Liu*, Xuezhi Gao, Zhanfang Fan, Tianfu Liu, Bo Li, Dangsheng Su, Qinghe Wang*, Maosheng Cheng*. A deoximation method for deprotection of ketones and aldhydes using a graphene-oxide-based co-catalysts system. Advanced Synthesis & Catalysis, 2019, 361(13): 3137–3145.